A carregar...
Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting
AIM: To describe trends of combination therapy (CT) of infliximab (IFX) and immunomodulator (IMM) for inflammatory bowel disease (IBD) in the community setting. METHODS: A retrospective study was conducted of all IBD patients referred for IFX infusion to our community infusion center between 04/01/0...
Na minha lista:
| Publicado no: | World J Gastrointest Pharmacol Ther |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5797978/ https://ncbi.nlm.nih.gov/pubmed/29430323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4292/wjgpt.v9.i1.8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|